Navigation Links
FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis
Date:5/12/2008

ST. DAVID'S, Bermuda and COPENHAGEN, Denmark, May 12 /PRNewswire-FirstCall/ -- Warner Chilcott and LEO Pharma announced today that the United States Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Taclonex Scalp(R) (calcipotriene 0.005% and betamethasone dipropionate 0.064%) Topical Suspension. LEO Pharma submitted the NDA for Taclonex Scalp(R) to the FDA in July 2007. Taclonex Scalp(R) is a topical suspension containing a combination of calcipotriene 0.005% and betamethasone dipropionate 0.064% for the treatment of moderate to severe psoriasis vulgaris of the scalp in adults. Taclonex Scalp(R) is called Xamiol(R) outside the United States.

"Taclonex Scalp(R) represents an exciting addition to our Taclonex(R) and Dovonex(R) franchise, expanding the treatment options for psoriasis patients in the U.S.," said Roger Boissonneault, CEO of Warner Chilcott Limited.

Warner Chilcott is LEO Pharma's exclusive licensee of Taclonex(R) and Dovonex(R) products in the United States. Warner Chilcott expects to launch Taclonex Scalp(R) in the second half of 2008. As a result of the FDA approval of Taclonex Scalp(R), Warner Chilcott will pay a milestone payment of $40 million to LEO Pharma in June 2008. Warner Chilcott will record the milestone payment as an intangible asset on its balance sheet and will amortize it over the useful life of the product.

Psoriasis is a chronic, inflammatory skin disease for which there is no cure. In plaque psoriasis (psoriasis vulgaris), the most common type, patches of skin called "lesions" become inflamed and are covered by silvery white scales. A non-contagious disorder, psoriasis can occur on any part of the body, and can significantly alter a sufferer's life both physically and mentally, including the ability to work, play and interact with others. Scalp psoriasis is very common. In fact, at least half of all people who have psoriasis have it on their scalp. As with psoriasis elsewhe
'/>"/>

SOURCE Warner Chilcott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. FDA Approves Health Claim for Brown Rice
2. FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents
3. FDA approves HeartMate II mechanical heart pump for heart-failure patients
4. FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD
5. FDA Approves New Once-a-Month Dose of Actonel for Postmenopausal Osteoporosis
6. FDA approves VYVANSE, first and only once-daily prodrug stimulant to treat ADHD in adults
7. FDA APPROVES ROTARIX(R) [Rotavirus Vaccine, live, oral], THE FIRST VACCINE LICENSED TO COMPLETE THE ROTAVIRUS IMMUNIZATION SERIES BY FOUR MONTHS OF AGE
8. House Overwhelmingly Approves Renewal and Tripling of Successful U.S. Global AIDS Prevention Effort
9. VeriPrime Approves New Best Practices for Beef Production
10. U.S. EPA Approves Registration of Antimicrobial Copper Alloys
11. Arizona Senate Approves Smoking Cessation Treatments for State Medicaid Beneficiaries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Swedish study shows that adolescents who suffer from sleep ... to succeed academically compared to those who enjoy a ... in the journal Sleep Medicine . , In ... between 12 and 19 from Uppsala County, researchers from ... habitual short sleep duration (less than 7 hours per ...
(Date:9/23/2014)... San Jose, California (PRWEB) September 23, 2014 ... – Medical transcription is the process of translating ... assessment, clinical course, therapeutic procedures, and prognosis, into ... health insurance agents, patients, and healthcare providers. With ... documentation of each patient’s condition, outsourcing of such ...
(Date:9/23/2014)... If you or a loved one ... treatment may be a challenge. Fortunately, an inventor from ... is designed to improve the experience. , He developed ... having to remove, tear or reposition their clothing. Furthermore, ... their dignity. At the same time, it safeguards their ...
(Date:9/23/2014)... be able to grow enough food there to maintain ... food in NASA,s Orion spacecraft on the year-long trip ... extreme conditions? These are questions scientists are trying to ... International Space Station (ISS). , Plant biology investigations called ... to adapt to a microgravity environment. When a crew ...
(Date:9/23/2014)... allow electrical signals to pass unhindered through new ... Texas Children,s Hospital. , A team led by ... Matteo Pasquali created the patches infused with conductive ... a sponge-like bioscaffold that contains microscopic pores and ... overcome a limitation of current patches in which ...
Breaking Medicine News(10 mins):Health News:Expanding Healthcare Sector Drives Demand for Medical Transcription Services, According to New Report by Global Industry Analysts, Inc. 2Health News:Expanding Healthcare Sector Drives Demand for Medical Transcription Services, According to New Report by Global Industry Analysts, Inc. 3Health News:Apparel for Dialysis Patients Invented by InventHelp Client (CBA-2492) 2Health News:Getting to the root of the problem in space 2Health News:Getting to the root of the problem in space 3Health News:Getting to the root of the problem in space 4Health News:Nanotubes help healing hearts keep the beat 2Health News:Nanotubes help healing hearts keep the beat 3
... revolutionary EnviroCool fresh air cooling system also ... air pollution, WINCHESTER, Calif., June 11 With ... on the rise, homeowners around the,country are turning to ... cool their homes: QuietCool and EnviroCool., The QuietCool ...
... HMS Holdings Corp. (Nasdaq:,HMSY) today announced that it will ... held June 24-26, 2008 in New York,City., Walter ... Corp.,will present on Tuesday, June 24th at 10:15 am ... presentation can be accessed through,our website at http://www.hmsholdings.com/news/presentations.asp ...
... Research Group, offering hope to sufferers of asbestos-related ... today. , Special guest Karen Banton, widow of ... the group, saying: , "Today brings hope of ... asbestos exposure and ultimately a future free of ...
... Award Presented to QualityMetric Employee at Annual ... ... 11 In recognition of clinical,research to improve the understanding ... Senior Scientist with,QualityMetric(TM) Health Outcomes Solutions, was presented the 2008-2009,American ...
... Patient Share by 2012, According to a ... New Report from Decision Resources, ... the,world,s leading research and advisory firms focusing on pharmaceutical and,healthcare ... of,fistulas in a greater percentage of patients than,Centocor/Schering-Plough/Mitsubishi Tanabe,s Remicade ...
... in children may have an impact on cardiovascular functioning ... according to a research abstract that will be presented ... the Associated Professional Sleep Societies (APSS). , The study, ... of Melbourne and Monash University, Melbourne, Victoria, Australia, focused ...
Cached Medicine News:Health News:A Far Less Expensive, Green Alternative to Traditional Air Conditioning, from QuietCool 2Health News:New research group offers hope to asbestosis sufferers 2Health News:New research group offers hope to asbestosis sufferers 3Health News:QualityMetric Senior Scientist Min Yang, MD, PhD, Recipient of Prestigious Clinical Research Award in Women's Health 2Health News:QualityMetric Senior Scientist Min Yang, MD, PhD, Recipient of Prestigious Clinical Research Award in Women's Health 3Health News:A Drug With Efficacy Superior to That of Remicade at Inducing Closure and Healing of Fistulas Would Earn a 30 Percent Patient Share in the Crohn's Disease Drug Market 2Health News:Primary snoring in children impacts cardiovascular functioning 2Health News:Primary snoring in children impacts cardiovascular functioning 3
(Date:9/23/2014)... CHICAGO , Sept. 23, 2014  Hill-Rom (NYSE: ... agreement with Providence Health ( Renton, WA ... new agreement expands the companies, existing relationship as Hill-Rom ... Maternal, and Bariatric capital bed frame and surface products. ... largest health systems in the U.S.  It operates 34 ...
(Date:9/23/2014)... , Sept. 23, 2014 Research ... "Biopharmaceutical and Vaccine Production Markets" report to ... many new therapies and vaccines - including products to ... are still huge challenges during the final stages of ... when and how to risk production capital to upscale ...
(Date:9/23/2014)... 23, 2014 Rising health ... and increasing number of foreign and domestic players in ... India   The ... most high growth potential markets worldwide due to multiple ... among the youth, changing food consumption patterns, increasing diabetic ...
Breaking Medicine Technology:Hill-Rom Announces Seven-Year, Sole-Source Contract with Providence Health 2Biopharmaceutical and Vaccine Production Markets 2Biopharmaceutical and Vaccine Production Markets 3India Probiotic Market Pegged to Grow at Around 20% by 2019, Says TechSci Research 2India Probiotic Market Pegged to Grow at Around 20% by 2019, Says TechSci Research 3
... 10th Annual Superbugs and Superdrugs Conference on ... ... 10 Enanta Pharmaceuticals, a,leader in the development of small ... program to,evaluate a new macrolide-related drug class, Bicyclolides, in the ...
... - Strategic Collaboration with the National Cancer Institute,s NABTT ... ... 10 BiPar Sciences, Inc. today,announced the expansion of the clinical ... the most,common glioma in adults. BSI-201, the first poly ADP-ribose polymerase,(PARP) ...
Cached Medicine Technology:Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA 2Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA 3BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer 2
... Eliminate aerosol contamination, which ... in PCR. Hydrophobic, nonwicking ... air can pass through ... in contrast to tips ...
... Aerosol barrier tips eliminate false ... Scientifically designed and tested, Promega Barrier ... working with amplified nucleic acids (PCR(a)), ... samples, forensic and serological specimens. , ...
Hydrophobic PE filter without self-sealing additives, permits sample recovery after accidental over-pipetting. All filters are sterile (to USP, DAB, Ph.Eur. standards) and PCR clean (free from human ...
... Finntip Filters are ideal ... methods, or for any work ... They are designed for pipetting ... samples, and other. For applications ...
Medicine Products: